Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.

Pighi C, Cheong TC, Compagno M, Patrucco E, Arigoni M, Olivero M, Wang Q, Lopez C, Bernhart SH, Grande BM, Poggio T, Langellotto F, Bonello L, Dall'Olio R, Martinez-Martin S, Molinaro L, Francia di Celle P, Whitfield JR, Soucek L, Voena C, Calogero RA, Morin RD, Staudt LM, Siebert R, Zamo A, Chiarle R
Blood Adv. 2021 Dec 14;5(23):5239-5257. doi: 10.1182/bloodadvances.2021005682. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.